Many people plateau at doses of 0.5-1.0 mg weekly, but clinical data shows additional weight loss can occur at higher dosesup to 2.4 mg weeklyif side effects remain manageable
p = 0.02) were slightly protective against admission
The name change matters because it points to what this condition really is: a whole-body endocrine and metabolic condition, not simply an ovary problem
You just start to know something
this may result in preferential inclusion of individuals who may be healthier or more adherent, or who can better manage their health or receive better care, for example, due to requiring both baseline and follow-up HbA1c and weight measurements, as well as requiring continuous enrollment and at least 1 year of follow-up
This is the easiest phase, and it is also the most important time to solidify habits because the real challenges come later